Expert Opinion on Biological Therapy, Volume 21, Issue 1 (2021)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Biological Therapy, Volume 21, Issue 1 (2021)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Volume 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Biosimilars

Drug Profile

Article
LBEC0101, an etanercept biosimilar for the treatment of rheumatoid arthritis
Yeong Wook Song, Yong-Beom Park & Jinseok Kim
Pages: 1-8
Published online: 20 Dec 2019
AbstractforLBEC0101, an etanercept biosimilar for the treatment of rheumatoid arthritis | Full Text | References | PDF (1 MB) | EPUB
  • 2055 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Perspective

A health economic guide to market access of biosimilars
Steven Simoens & Arnold G. Vulto
Pages: 9-17
Published online: 05 Jan 2021
AbstractforA health economic guide to market access of biosimilars | Full Text | References | PDF (3 MB) | EPUB
  • 6409 Views
  • 17 CrossRef citations
  • 0Altmetric
Open Access

Review

Approval of biosimilars: a review of unsuccessful regulatory filings
Anurag S. Rathore, Hemlata Chhabra & Ankita Bhargava
Pages: 19-28
Published online: 04 Sep 2020
AbstractforApproval of biosimilars: a review of unsuccessful regulatory filings | Full Text | References | PDF (349 KB) | EPUB
  • 498 Views
  • 7 CrossRef citations
  • 0Altmetric
Anti-TNF biosimilars in rheumatology: the end of an era?
Mrinalini Dey, Sizheng Steven Zhao & Robert J. Moots
Pages: 29-36
Published online: 12 Aug 2020
AbstractforAnti-TNF biosimilars in rheumatology: the end of an era? | Full Text | References | PDF (331.6 KB) | EPUB
  • 385 Views
  • 5 CrossRef citations
  • 0Altmetric
Evolution of infliximab biosimilar in inflammatory bowel disease: from intravenous to subcutaneous CT-P13
Tommaso Lorenzo Parigi, Ferdinando D’Amico, Laurent Peyrin-Biroulet & Silvio Danese
Pages: 37-46
Published online: 31 Aug 2020
AbstractforEvolution of infliximab biosimilar in inflammatory bowel disease: from intravenous to subcutaneous CT-P13 | Full Text | References | PDF (332.3 KB) | EPUB
  • 441 Views
  • 8 CrossRef citations
  • 0Altmetric
Nocebo effect and biosimilars in inflammatory bowel diseases: what’s new and what’s next?
Ferdinando D’Amico, Virginia Solitano, Laurent Peyrin-Biroulet & Silvio Danese
Pages: 47-55
Published online: 06 Sep 2020
AbstractforNocebo effect and biosimilars in inflammatory bowel diseases: what’s new and what’s next? | Full Text | References | PDF (1.5 MB) | EPUB
  • 379 Views
  • 10 CrossRef citations
  • 0Altmetric
Real-world observational study of biosimilars in inflammatory arthritis treatment: a systematic literature review
Ji-Won Kim, Ju-Yang Jung & Chang-Hee Suh
Pages: 57-73
Published online: 16 Oct 2020
AbstractforReal-world observational study of biosimilars in inflammatory arthritis treatment: a systematic literature review | Full Text | References | PDF (1.1 MB) | EPUB
  • 418 Views
  • 8 CrossRef citations
  • 0Altmetric
Anti-tumor necrosis factor agents in psoriasis: addressing key challenges using biosimilars
Francesca Prignano, Jaeyun Choi, Burkhard Pieper & Lars Iversen
Pages: 75-80
Published online: 04 Sep 2020
AbstractforAnti-tumor necrosis factor agents in psoriasis: addressing key challenges using biosimilars | Full Text | References | PDF (386.6 KB) | EPUB
  • 3287 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access

Meta-opinion

Article
Biosimilars in psoriasis: what should your positioning be?
Ricardo Ruiz-Villaverde & Manuel Galán-Gutierrez
Pages: 81-86
Published online: 27 Jul 2020
AbstractforBiosimilars in psoriasis: what should your positioning be? | Full Text | References | PDF (284.3 KB) | EPUB
  • 228 Views
  • 7 CrossRef citations
  • 0Altmetric

Original Research

Article
Similar efficacy, safety, and immunogenicity of the biosimilar BI 695501 and adalimumab reference product in patients with moderate-to-severe chronic plaque psoriasis: results from the randomized Phase III VOLTAIRE-PSO study
Alan Menter, Petr Arenberger, Sigrid Balser, Stefan Beissert, Ashley Cauthen, Niklas Czeloth, Jennifer Soung, Sasha Jazayeri, Peter Weisenseel & Girish Jayadeva
Pages: 87-96
Published online: 29 Dec 2020
AbstractforSimilar efficacy, safety, and immunogenicity of the biosimilar BI 695501 and adalimumab reference product in patients with moderate-to-severe chronic plaque psoriasis: results from the randomized Phase III VOLTAIRE-PSO study | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 2992 Views
  • 9 CrossRef citations
  • 0Altmetric
Open Access
Article
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients
Daniela Pugliese, Luisa Guidi, Giuseppe Privitera, Lorenzo Bertani, Barbara Tolusso, Luigi Giovanni Papparella, Simona Maltinti, Clara Di Mario, Sara Onali, Linda Ceccarelli, Gian Lodovico Rapaccini, Franco Scaldaferri, Elisa Gremese, Antonio Gasbarrini, Francesco Costa & Alessandro Armuzzi
Pages: 97-104
Published online: 31 Oct 2020
AbstractforSwitching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients | Full Text | References | PDF (1.7 MB) | EPUB
  • 235 Views
  • 3 CrossRef citations
  • 0Altmetric
Article
QL0902, a proposed etanercept biosimilar: pharmacokinetic and immunogenicity profile to its reference product in healthy Chinese male subjects
Yun Zeng, Jie Huang, Chang Cui, Shuang Yang, Ze-Yu Zhang, Saqib Ali, Zhi-Jun Huang & Guo-Ping Yang
Pages: 105-110
Published online: 21 Mar 2020
AbstractforQL0902, a proposed etanercept biosimilar: pharmacokinetic and immunogenicity profile to its reference product in healthy Chinese male subjects | Full Text | References | PDF (851.5 KB) | EPUB
  • 186 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Knowledge and awareness of biosimilars and shared decision-making among gastroenterology team members in Colorado, USA
Rovshan M. Ismailov, Lieven Pouillon, Christian P. Selinger & Zaytuna D. Khasanova
Pages: 111-119
Published online: 01 Nov 2020
AbstractforKnowledge and awareness of biosimilars and shared decision-making among gastroenterology team members in Colorado, USA | Full Text | References | PDF (580.6 KB) | EPUB | Supplemental
  • 125 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles